Application 209540
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AZACITIDINE | AZACITIDINE | POWDER;INTRAVENOUS, SUBCUTANEOUS | 100MG/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16714-777 | Azacitidine | Azacitidine | NorthStar RxLLC | ANDA | Current |
| 69097-368 | Azacitidine | Azacitidine | Cipla USA Inc. | ANDA | Current |
| 69097-368 | Azacitidine | Azacitidine | Cipla USA Inc. | ANDA | Current |
| 69097-368 | Azacitidine | Azacitidine | Cipla USA Inc. | ANDA | Current |
| 69097-368 | Azacitidine | Azacitidine | Cipla USA Inc. | ANDA | Current |